Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-11

Clinical Trial Update: Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of low-dose terazosin in subjects undergoing carotid artery stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terazosin (terazosin)

Snippet

Sponsor: Capital Medical University | Conditions: Carotid Artery Stenosis | Phase 2 | Status: UNKNOWN